Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrienne Morey

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
BMJ Case Reports|December 25, 2014
Adrenal tumours: how to establish malignancyVanita Toogood, Sam Milliken, Adrienne Morey, et al.
Neurosurgical Review|July 18, 2025
Surgical outcomes in diffuse leptomeningeal glioneuronal tumours: a systematic review and individual patient data meta-analysisBarry Ting Sheen Kweh, Adrienne Morey, Peter Mews
The Australasian Journal of Dermatology|February 22, 2011
Atypical Gianotti-Crosti syndrome in two HIV and hepatitis B co-infected adultsRaymond Cocciolone, Adrienne Morey, Patrycja Panasiuk, et al.
BMJ Case Reports|May 11, 2021
Hypocomplementemic urticarial vasculitis syndrome presenting with bilateral scleritisElla Claire Berry, Jane Wells, Adrienne Morey, et al.
Pathology|April 4, 2006
Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistryMichael Bilous, Adrienne Morey, Jane Armes, et al.
BMC Cancer|November 27, 2012
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic diseaseArlene Chan, Adrienne Morey, Belinda Brown, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 24, 2006
Refinement of immunohistologic parameters for Her2/neu scoring validation by FISH and CISHAnthony S-Y Leong, Mark Formby, Zenobia Haffajee, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatmentPuey Ling Chia, Hongdo Do, Adrienne Morey, et al.
Asia-Pacific Journal of Clinical Oncology|February 28, 2019
Combined immune therapy grade IV dermatitis in metastatic melanomaManreet Randhawa, Christine Archer, Gregory Gaughran, et al.
World Journal of Clinical Oncology|December 5, 2019
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case reportManreet Randhawa, Gregory Gaughran, Christine Archer, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|December 25, 2014
Adrenal tumours: how to establish malignancyVanita Toogood, Sam Milliken, Adrienne Morey, et al.
Neurosurgical Review|July 18, 2025
Surgical outcomes in diffuse leptomeningeal glioneuronal tumours: a systematic review and individual patient data meta-analysisBarry Ting Sheen Kweh, Adrienne Morey, Peter Mews
The Australasian Journal of Dermatology|February 22, 2011
Atypical Gianotti-Crosti syndrome in two HIV and hepatitis B co-infected adultsRaymond Cocciolone, Adrienne Morey, Patrycja Panasiuk, et al.
BMJ Case Reports|May 11, 2021
Hypocomplementemic urticarial vasculitis syndrome presenting with bilateral scleritisElla Claire Berry, Jane Wells, Adrienne Morey, et al.
Pathology|April 4, 2006
Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistryMichael Bilous, Adrienne Morey, Jane Armes, et al.
BMC Cancer|November 27, 2012
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic diseaseArlene Chan, Adrienne Morey, Belinda Brown, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 24, 2006
Refinement of immunohistologic parameters for Her2/neu scoring validation by FISH and CISHAnthony S-Y Leong, Mark Formby, Zenobia Haffajee, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatmentPuey Ling Chia, Hongdo Do, Adrienne Morey, et al.
Asia-Pacific Journal of Clinical Oncology|February 28, 2019
Combined immune therapy grade IV dermatitis in metastatic melanomaManreet Randhawa, Christine Archer, Gregory Gaughran, et al.
World Journal of Clinical Oncology|December 5, 2019
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case reportManreet Randhawa, Gregory Gaughran, Christine Archer, et al.
Pageof 3